inspect molecule / dermarad relief post radiation calming liquid
Dermarad Relief Post Radiation Calming Liquid
Lidocaine 3 Percent o--o \/ /\ o--o
Lidocaine 3 Percent is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.
active moietyLidocaine 3 Percent
administration routeOral
price comparison status2 snapshots
safety signal rating46 / 100
human-drug-labelDailyMed SPL indexDailyMed SPL
price index
Typical Class Estimates
⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: human-drug-label.
$24.50USvsCA$14.20CA
- US Typical Class Average · US$24.50
30 tablets · acquisition-reference · Molecule Index Class Benchmark ↗
- CA Typical Class Average · CACA$14.20
30 tablets · formulary-benefit-price · Molecule Index Class Benchmark ↗
Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.
query trend --id 37476 --12m
Price Trend Index
Deterministic trailing 12-month value delta index for this active ingredient class.
Rising Fast3M: +1.6%12M: +6.5%
Jul 2025Jun 2026
Jan 2026$23.81
Feb 2026$23.89
Mar 2026$24.13
Apr 2026$24.21
May 2026$24.28
Jun 2026$24.52
01 / chemistryMaker not enriched yet
Ingredient Breakdown
active moietyLidocaine 3 Percent
formulationOral human-drug-label
mechanism of action
human-drug-label
available strengths
Strength varies by package/NDC; inspect source label before comparing prices.
02 / ingredientsexcipients
Excipients / Maker Notes
- Not enriched yet from label source.
Manufacturer Notes
- This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals
Steps To Take Safely
- Confirm ingredient, dose, timing, food instructions, and interaction warnings with a clinician or pharmacist.
- Use the same ingredient name when comparing brand, generic, country, and pharmacy options.
- Do not split, crush, stop, or substitute extended-release products unless the label or clinician says so.
- Watch for severe allergic reactions, bleeding, mood changes, breathing issues, or other label-specific red flags.
Side-Effect Signals
- label-specific reactions
- allergic reaction
- interaction risk
- dose/formulation confusion
- urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.
$ grep ingredient --same